Press Releases

  • Rho Recognized for Exemplary Workplace Practice

    Receives prestigious When Work Works Award for the fourth time   Chapel Hill, NC (June 15, 2016) – Rho, a full service contract research organization (CRO) focused on bringing new products to market

    Jun 20, 2016

  • Definiens to Present at First Rational Combinations 360° Conference in New York

    MUNICH, GERMANY - Jun 20, 2016 - Definiens, the pioneer in Tissue Phenomics solutions for diagnostics development and commercialization, today announced that chief commercial officer Merrilyn Datta, PhD, will present at Rational Combinations 360°, being held in New York, NY from June 23-24, 2016

    Jun 20, 2016

  • Bioclinica debuts two divisions focused on patient engagement

    DOYLESTOWN, PA - Jun 15, 2016 - Bioclinica®, a specialty clinical trials technology and services provider, today announced the debut of two new divisions, creating an integrated offering focused on patient engagement

    Jun 15, 2016

  • ERT Brings Innovative Patient Data Collection Concepts to Clinical Researchers

    PHILADELPHIA, PA, UNITED STATES - Jun 16, 2016 - ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, today announced that its’ Innovation Lab will travel to the Drug Information Association (DIA) Annual Meeting to give clinical researchers access to advanced models for clinical trials and patient data collection

    Jun 15, 2016

  • WIRB-Copernicus Group Acquires Data and Technology from karmadata

    PRINCETON, NJ - Jun 15, 2016 - WIRB-Copernicus Group® (WCG™), one of the world's leading providers of solutions that measurably improve the quality and efficiency of clinical research, today announced an industry-transforming agreement with karmadata, the market leader in clinical trial database and decision support applications

    Jun 15, 2016

  • ERT Introduces Centralized DLCO Services for Respiratory Trials

    PHILADELPHIA, PA, UNITED STATES - Jun 15, 2016 - ERTIntroduces Centralized DLCO Services for Respiratory TrialsCentralization reduces data variability, improves trial efficiencies ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, today introduced its  Centralized Services  for assessing diffusing capacity of the lungs for carbon monoxide (DLCO) data in respiratory clinical trials

    Jun 15, 2016

  • Rho to Recruit New Team Members for 30 Open Positions During DIA 2016 Annual Meeting

    CHAPEL HILL, NC, UNITED STATES - Jun 8, 2016 - WHAT:  Rho, a full-service contract research organization (CRO), is making the most of its presence at one of the industry's leading events by seeking out talent to fill a number of clinical research positions during the Drug Information Association (DIA) 2016 Annual Meeting, the largest global interdisciplinary event for disciplines involved in the discovery, development and life cycle management of health care products

    Jun 8, 2016

  • Certara and the FDA Extend Their Partnership to Develop PBPK Models to Support Veterinary Drug Evaluations

    PRINCETON, NJ - Jun 8, 2016 - Certara®, the global biosimulation technology-enabled drug development company, today announced that the US Food and Drug Administration’s (FDA’s) Center for Veterinary Medicine has extended its five-year Cooperative Research and Development Agreement (CRADA) with the company until 2020

    Jun 8, 2016

  • Definiens and MolecularMD Announce Partnership to Combine IHC Assays with Advanced Digital Pathology and Data Mining

    MUNICH, UNITED STATES - Jun 7, 0016 - Definiens, the pioneer in Tissue Phenomics solutions for diagnostics development and commercialization, today announced a partnership agreement with MolecularMD to combine MolecularMD’s expertise in specialty diagnostic assays with Definiens’ quantitative tissue read-outs

    Jun 7, 2016

  • Rho-Supported Study Wins the David Sackett Trial of the Year Award from the Society for Clinical Trials

    CHAPEL HILL, NC, UNITED STATES - Jun 7, 2016 - Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, was recently honored as part of the clinical trial team for the LEAP Trial: Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy

    Jun 7, 2016

  • Former NCI and NIH Director Dr. Harold Varmus Joins The International Biomedical Research Alliance Board

    BETHESDA, MD - Jun 2, 2016 - The International Biomedical Research Alliance, a non-profit organization which provides programming and funding support for the National Institutes of Health (NIH) Oxford-Cambridge Scholars Program, today announced that Harold Varmus, MD, is joining the Alliance’s board of directors

    Jun 2, 2016

  • Rho Named Best CRO with Life Sciences Award from Triangle Business Journal

    CHAPEL HILL, NC, UNITED STATES - May 31, 2016 - Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, recently announced that the company was named the 2016 Best CRO by Triangle Business Journal, a multimedia source for local business news, research and events in the Raleigh, Durham and Chapel Hill region of North Carolina, where Rho is headquartered

    May 31, 2016

  • Certara and The University of Manchester Co-host Inaugural Model-based Personalized Drug Dosing in Healthcare Conference

    PRINCETON, NJ - May 25, 2016 - Certara®, the global biosimulation technology-enabled drug development company, in partnership with The University of Manchester, successfully organized the first-ever Health Care Summit on Model-based Precision Dosing on May 19-20 in the UK

    May 25, 2016

  • Rho Donates $28,000 to the March of Dimes

    CHAPEL HILL, NC, UNITED STATES - May 24, 0016 - Rho Donates $28,000 to the March of DimesChapel Hill-based company hosts a variety of employee events to help raise funds for charity Chapel Hill, NC  ̶  May 24, 2016  ̶  Rho, a Chapel Hill-based full-service contract research organization (CRO) focused on bringing new products to market through a complete range of product development services, announced today that it has donated $28,000 to the March of Dimes

    May 24, 2016

  • ERT Integrates Circassia’s FeNO Device to Assess Patient Airway Inflammation

    PHILADELPHIA, PA, UNITED STATES - May 17, 2016 - ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, today announced it has successfully integrated the market-leading Fractional exhaled Nitric Oxide (FeNO) measurement device by Aerocrine—a Circassia subsidiary— into ERT’s diagnostic platform for spirometry, ECG and home monitoring for centralized clinical trials

    May 17, 2016

  • Dr. Adam Darwich is Appointed Certara Lecturer in Precision Dosing at The University of Manchester, England

    PRINCETON, NJ - May 12, 2016 - Certara®, the global biosimulation technology-enabled drug development company, today announced that Adam Darwich, PhD, has been appointed Certara Lecturer in Precision Dosing at the Manchester Pharmacy School at The University of Manchester in England

    May 12, 2016

  • Clintrax Global Named as Finalist for Triangle Business Journal’s 2016 Life Sciences Awards

    PRINCETON, NJ - May 11, 2016 - WIRB-Copernicus Group® (WCG™), one of the world's leading providers of solutions that measurably improve the quality and efficiency of clinical research, today announced that its Clintrax Global company has been named a finalist for the Triangle Business Journal’s (TBJ’s) 2016 Life Sciences Awards

    May 11, 2016

  • Definiens’ Symposium Finds Tissue Context of Tumor is Key to Cancer Immunotherapy Success

    MUNICH, GERMANY - May 10, 2016 - Definiens, the pioneer in Tissue Phenomics® solutions for diagnostics development, has announced findings from the International Symposium, a sold-out gathering of international researchers and clinicians on April 27-28 in Boston, Massachusetts to discuss advancements in oncology and the application of Tissue Phenomics

    May 10, 2016

  • PharmaSeek Partners with PRCCI to Enhance Clinical Research in Puerto Rico

    MIDDLETON, WI, UNITED STATES - May 4, 2016 - PharmaSeek LLC, an Investigative Site Network (ISN), is expanding the reach of its network by partnering with the Puerto Rico Consortium for Clinical Investigation (PRCCI)

    May 4, 2016

  • Certara Launches New E-learning Platform for Biosimulation Education

    PRINCETON, NJ - Apr 28, 2016 - Certara®, the global biosimulation technology-enabled drug development company, today launched an e-learning platform through Certara University to satisfy the increased need for education in the burgeoning field of biosimulation or model-based drug development

    Apr 28, 2016